Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed director
Quarterly results
CC transcript
|
|
ENDOLOGIX INC (ELGX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/17/2020 |
4
| Lemaitre Dan (Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Sold 2,582 shares
@ $0.05, valued at
$129.1
Sold 33,709 shares
@ $0.0501, valued at
$1.7k
Sold 15,553 shares
@ $0.0521, valued at
$810.3 |
|
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2020 |
4
| Kiernan Jane E (Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 103,847 shares
@ $0 |
|
| 02/04/2020 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 1,914 shares
@ $0
Paid exercise price by delivering 783 shares
@ $1, valued at
$783 |
|
| 01/09/2020 |
4
| Zehren John (Chief Commercial Officer) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 20,000 shares
@ $0
Paid exercise price by delivering 2,726 shares
@ $1.98, valued at
$5.4k
|
|
| 01/02/2020 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 47,011 shares
@ $0
Paid exercise price by delivering 5,278 shares
@ $1.68, valued at
$8.9k
|
|
| 01/02/2020 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 47,010 shares
@ $0
Paid exercise price by delivering 3,393 shares
@ $1.68, valued at
$5.7k
|
|
| 12/17/2019 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 47,010 shares
@ $0
Paid exercise price by delivering 2,986 shares
@ $2.545, valued at
$7.6k
|
|
| 11/13/2019 |
4
| WALLER GREGORY D (Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Sold 582 shares
@ $3, valued at
$1.7k
|
|
| 10/07/2019 |
4
| HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 12,500 shares
@ $0
Paid exercise price by delivering 4,210 shares
@ $3.53, valued at
$14.9k
|
|
| 10/01/2019 |
4
| Onopchenko John (CEO and Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 19,034 options to buy
@ $53, valued at
$1M
Disposed/sold 19,864 options to buy
@ $43.6, valued at
$866.1k
Granted 12,968 options to buy
@ $4.71, valued at
$61.1k
|
|
| 10/01/2019 |
4
| Fecho Jeff (Chief Quality Officer) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 6,789 options to buy
@ $56.7, valued at
$384.9k
Granted 2,263 options to buy
@ $4.71, valued at
$10.7k
|
|
| 10/01/2019 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 13,702 options to buy
@ $135.6, valued at
$1.9M
Disposed/sold 11,594 options to buy
@ $75.3, valued at
$873k
Disposed/sold 10,999 options to buy
@ $48.2, valued at
$530.2k
Granted 10,959 options to buy
@ $4.71, valued at
$51.6k
|
|
| 10/01/2019 |
4
| Thompson Matthew (Chief Medical Officer) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 8,999 options to buy
@ $48.2, valued at
$433.8k
Disposed/sold 9,907 options to buy
@ $69.1, valued at
$684.6k
Granted 6,304 options to buy
@ $4.71, valued at
$29.7k
|
|
| 10/01/2019 |
4
| Wilder Thomas (Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 1,250 options to buy
@ $43.6, valued at
$54.5k
Granted 417 options to buy
@ $4.71, valued at
$2k
|
|
| 10/01/2019 |
4
| Lemaitre Dan (Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 5,000 options to buy
@ $43.8, valued at
$219k
Disposed/sold 2,000 options to buy
@ $43.6, valued at
$87.2k
Disposed/sold 2,000 options to buy
@ $82.6, valued at
$165.2k
Granted 2,834 options to buy
@ $4.71, valued at
$13.3k
|
|
| 10/01/2019 |
4
| HAYDEN JEREMY B. (General Counsel) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 23,601 options to buy
@ $42.1, valued at
$993.6k
Granted 7,868 options to buy
@ $4.71, valued at
$37.1k
|
|
| 08/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2019 |
4
| Onopchenko John (CEO and Director) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 167,870 shares
@ $0
Granted 497,041 options to buy
@ $6.67, valued at
$3.3M
|
|
|
|
|